<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>同写意 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-14T20:34:46+08:00</updated>
  <subtitle>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>写意发布丨Cytiva向龙沙交付模块化生物制品工厂</title>
    <updated>2021-01-14T19:05:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/QQkYkMFRQIOLlk2ocHHuKA</id>
    <link href="https://mp.weixin.qq.com/s/QQkYkMFRQIOLlk2ocHHuKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨中国首个自主创新微球制剂瑞欣妥在华获批</title>
    <updated>2021-01-14T19:05:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/LIN5mp1uPHMhjGoR52QvNw</id>
    <link href="https://mp.weixin.qq.com/s/LIN5mp1uPHMhjGoR52QvNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨润东医药与丽珠医药集团股份有限公司达成战略合作</title>
    <updated>2021-01-14T19:05:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/ZlnhlcpVYldf6T3A_COWVg</id>
    <link href="https://mp.weixin.qq.com/s/ZlnhlcpVYldf6T3A_COWVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨百济神州PD-1正式获批一线鳞状NSCLC适应症</title>
    <updated>2021-01-14T19:05:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/xwlt6inaV_e2BzbdJuxEbA</id>
    <link href="https://mp.weixin.qq.com/s/xwlt6inaV_e2BzbdJuxEbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意云课丨第64期：美国处方药市场与定价简析（上）</title>
    <updated>2021-01-14T19:05:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/Ggg0iWw_dXH9BFQnPUih_w</id>
    <link href="https://mp.weixin.qq.com/s/Ggg0iWw_dXH9BFQnPUih_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访童友之丨另辟蹊径，普克鲁胺或将成为新冠治疗“人民的新希望”</title>
    <updated>2021-01-13T18:46:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/bJ8GGVhRNavao8WKtuv5SQ</id>
    <link href="https://mp.weixin.qq.com/s/bJ8GGVhRNavao8WKtuv5SQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为什么Moderna的新冠疫苗能脱颖而出？</title>
    <updated>2021-01-13T18:46:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/NFSJiHrTGavtOF2nnfZnSg</id>
    <link href="https://mp.weixin.qq.com/s/NFSJiHrTGavtOF2nnfZnSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>杰克说药丨美国乡下白人的悲歌（上）</title>
    <updated>2021-01-12T18:30:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/V4R3_7aY84lVxO9YF903Dw</id>
    <link href="https://mp.weixin.qq.com/s/V4R3_7aY84lVxO9YF903Dw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨博腾股份2020年度业绩预增</title>
    <updated>2021-01-12T18:30:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/igMnBpfL9ab4tuCxqZBrcw</id>
    <link href="https://mp.weixin.qq.com/s/igMnBpfL9ab4tuCxqZBrcw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨5亿美元B轮融资，基石药业海外合作伙伴EQRx加速产品开发</title>
    <updated>2021-01-12T18:30:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/q0POrV_2vXAzG0JWM5uwGQ</id>
    <link href="https://mp.weixin.qq.com/s/q0POrV_2vXAzG0JWM5uwGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意报告丨多肽药物非临床安全性评估的介绍</title>
    <updated>2021-01-11T20:40:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/ckRKZvriFQ9sHaMTc6XlLg</id>
    <link href="https://mp.weixin.qq.com/s/ckRKZvriFQ9sHaMTc6XlLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨天境生物创始人臧敬五博士入选「2020上市公司领军人物」50强</title>
    <updated>2021-01-11T20:40:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/JOiwTbLyKp7t9ut9okberQ</id>
    <link href="https://mp.weixin.qq.com/s/JOiwTbLyKp7t9ut9okberQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>First-in-class：大数据推动创新药物研发的思考与展望</title>
    <updated>2021-01-11T20:40:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/ViHWVems2zTrO_vHnSwCHQ</id>
    <link href="https://mp.weixin.qq.com/s/ViHWVems2zTrO_vHnSwCHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“药界黄埔”？盘点“先声系”人才创业版图</title>
    <updated>2021-01-10T13:41:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/gKgj48n_hVbEUhnAWUkafA</id>
    <link href="https://mp.weixin.qq.com/s/gKgj48n_hVbEUhnAWUkafA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA对神经退行性疾病基因疗法发表了初步观点</title>
    <updated>2021-01-10T13:41:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/i27zv4rTQSlyORsfzAQRQg</id>
    <link href="https://mp.weixin.qq.com/s/i27zv4rTQSlyORsfzAQRQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布︱开拓药业公布普克鲁胺治疗新冠女性受试者的中期数据</title>
    <updated>2021-01-10T13:41:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/KL1ykF8FqssHGCgSJc8xWg</id>
    <link href="https://mp.weixin.qq.com/s/KL1ykF8FqssHGCgSJc8xWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物医药投资项目专利尽职调查，价值与要点</title>
    <updated>2021-01-09T15:07:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/kFN-dZGb_GQveogyaxpNtQ</id>
    <link href="https://mp.weixin.qq.com/s/kFN-dZGb_GQveogyaxpNtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021摩根会议周期间 SAPA与BioNJ联合推出网络研讨会</title>
    <updated>2021-01-09T15:07:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/Nn7ToZtOwUG1fZfvPr980w</id>
    <link href="https://mp.weixin.qq.com/s/Nn7ToZtOwUG1fZfvPr980w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>如何打造中国版Moderna？窥探生命科学领域颠覆性创新顶级推手的商业路径</title>
    <updated>2021-01-09T15:07:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/yplGjT5UOB61RczU-wIr5A</id>
    <link href="https://mp.weixin.qq.com/s/yplGjT5UOB61RczU-wIr5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意人物｜王印祥：SHP2/KRAS的借船出海！</title>
    <updated>2021-01-08T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/UZ2-hYtXQMLARK_IvGO9oQ</id>
    <link href="https://mp.weixin.qq.com/s/UZ2-hYtXQMLARK_IvGO9oQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>